HD-OPM Archive
Topics › Brain health & dementia

MIND diet slowed cognitive decline most in people with high Alzheimer's blood biomarkers

Louis Nervegna · Jul 24, 2026 · ♥ 5 reactions · 3 comments · original Facebook post
Brain health & dementiaMediterranean, DASH, MIND & plant-forward diets
AI summary & key facts

A secondary analysis of the 3-year MIND trial in 602 adults aged 65-84 found that cognitive effects of the MIND diet differed by baseline blood levels of amyloid-beta 40 and p-tau181. Louis highlights the largest benefit in those with high biomarkers suggestive of early Alzheimer's.

The MIND diet slows cognitive decline the largest amount in people who have high blood markers of amyloid and tau indicative of early Alzheimer’s disease.

(The MIND diet is a combination of the traditional Mediterranean and DASH diets, which was specifically designed to improve brain health.)

NewsweekA diet was designed to fight Alzheimer's. Now scientists have made a discovery.A blood test may help identify who is most likely to benefit from a brain-healthy eating plan.newsweek.com

Link to journal paper:

Paper · J Alzheimers Dis · 2026Dietary intervention and cognition across Alzheimer's disease biomarker levels: The MIND clinical trial.BackgroundThe cognitive response to dietary interventions may differ according to levels of Alzheimer's disease-related plasma biomarkers.ObjectiveUsing data from the MIND clinical trial, we examined whether baseline biomarkers, including Aβ40, the Aβ42/40 ratio, and p-tau181, modified the association between the MIND diet and longitudinal change in global cognition.MethodsThe MIND randomized clinical trial enrolled…journals.sagepub.com

Quoted:

Researchers analyzed data from the MIND clinical trial and found that the cognitive effects of the MIND diet appeared to differ depending on participants' levels of Alzheimer's-related biomarkers in their blood before starting the intervention.

The MIND diet—a combination of elements from the Mediterranean and DASH diets—was developed to support brain health and has been linked in previous studies to a lower risk of cognitive decline and dementia.

The new analysis, published in the Journal of Alzheimer's Disease, focused on two blood biomarkers associated with Alzheimer's disease: amyloid-β40 and phosphorylated tau 181 (p-tau181). These proteins are linked to the amyloid plaques and tau tangles that are hallmarks of the disease.

Using data from 602 adults ages 65 to 84 who participated in the three-year MIND trial, researchers examined whether baseline biomarker levels influenced how cognition changed over time.

Participants entered the study without cognitive impairment and were randomly assigned either to follow the MIND diet or a control diet. The researchers found that levels of amyloid-β40 and p-tau181 modified the relationship between the diet and cognitive outcomes.

People with higher levels of these Alzheimer's-related biomarkers experienced greater improvements in cognitive scores when assigned to the MIND diet compared with those in the control group.

Lead author Dr. Klodian Dhana, an associate professor in the Department of Internal Medicine, said the findings raise the possibility that the MIND diet may be particularly helpful for individuals showing early biological signs of Alzheimer's disease.

"In our analysis of data from the MIND trial, we found that the association between the dietary intervention and cognition varied by how much beta-amyloid and phosphorylated tau individuals had in the blood at the start of the study," Dhana said.

He said that the results suggest the diet "may be more beneficial for individuals with higher levels of these blood biomarkers."

#minddietHD #alzheimersHD #amyloidHD #tauHD #amyloidb40HD #ptau181HD

Research cited

← newer: Cleveland Clinic links gut-bacteria byproduct TMAO to atrialolder: Blending bananas with berries does not cancel the berries' b →